Bill Maughan Stock Analyst Profile - Clear Street Research Coverage - Stocknear

Bill Maughan

Stock Analyst at Clear Street

(3.7)
# 2329
Out of 5,506 analysts
18
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

11 Stocks

Name Action PT Current % Upside Ratings Updated
DNTH Dianthus Therapeutic...
Initiates Coverage On: Buy
100
34.94 186.2% 1 Sep 17, 2025
YMAB Y-mAbs Therapeutics
Downgrades: Hold
26 9
n/a n/a 3 Aug 6, 2025
KRYS Krystal Biotech
Initiates Coverage On: Buy
190
183.36 3.62% 1 Jul 1, 2025
CRSP CRISPR Therapeutics
Downgrades: Hold
45
67.74 -33.57% 1 Jun 27, 2025
NKTX Nkarta
Maintains: Buy
16 15
2.13 604.23% 2 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 9
1.21 643.8% 1 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
63 67
34.21 95.85% 3 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
91 106
28.49 272.06% 3 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 24
0.5 4700% 1 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60
8.37 616.85% 1 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
94.29 -52.27% 1 Nov 2, 2023